Published preclinical data demonstrate unprecedented Ago2 loading following administration of single subcutaneous siRNA dose, leading to improved potency and durability in vivo versus comparator siRNA. | April 20, 2023
Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 2,020,000 shares, a growth of 32.0% from the March 15th total of 1,530,000 shares. Based on an average trading volume of 428,200 shares, […]
StockNews.com upgraded shares of Wave Life Sciences (NASDAQ:WVE – Get Rating) from a sell rating to a hold rating in a research report report published on Thursday morning. WVE has been the topic of several other reports. SVB Leerink boosted their target price on Wave Life Sciences from $2.00 to $7.00 and gave the company […]
StockNews.com upgraded shares of Wave Life Sciences (NASDAQ:WVE – Get Rating) from a sell rating to a hold rating in a research note issued to investors on Thursday. A number of other analysts have also commented on the company. SVB Leerink boosted their price target on Wave Life Sciences from $2.00 to $7.00 and gave […]
CAMBRIDGE, Mass., March 29, 2023 Wave Life Sciences Ltd. , a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases,. | March 29, 2023